enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
10.15
+0.32 (3.26%)
May 19, 2026, 4:00 PM EDT - Market closed
enVVeno Medical Market Cap
enVVeno Medical has a market cap or net worth of $6.65 million as of May 19, 2026. Its market cap has decreased by -88.54% in one year.
Market Cap
6.65M
Enterprise Value
-17.88M
1-Year Change
-88.54%
Ranking
Category
Stock Price
$10.15
Market Cap Chart
Since May 31, 2018, enVVeno Medical's market cap has decreased from $39.99M to $6.65M, a decrease of -83.36%. That is a compound annual growth rate of -20.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 6.44M | -0.64% |
| Dec 31, 2025 | 6.49M | -87.75% |
| Dec 31, 2024 | 52.96M | -22.63% |
| Dec 29, 2023 | 68.45M | 41.69% |
| Dec 30, 2022 | 48.31M | -22.58% |
| Dec 31, 2021 | 62.40M | 222.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trinity Biotech | 11.71M |
| Sintx Technologies | 9.07M |
| Vivos Therapeutics | 8.19M |
| Tenon Medical | 7.87M |
| Intelligent Bio Solutions | 7.65M |
| Biomerica | 7.35M |
| Co-Diagnostics | 7.13M |
| Nexalin Technology | 6.92M |